Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep169 | Reproduction, endocrine disruptors and signalling | ECE2015

Differential cell cycle control protein profiles characterise bronchial carcinoids sensitive to mTOR inhibitors

Benfini Katiuscia , Gagliano Teresa , Gentilin Erica , Riva Eleonora , Falletta Simona , Di Pasquale Carmelina , Bondanelli Marta , Ambrosio Maria Rosaria , degli Uberti Ettore Ciro , Zatelli Maria Chiara

Background: Bronchial carcinoids (BC) are rare neoplasm, still orphan of medical therapy, which arise from neuroendocrine cells. It has been previously demonstrated that the atypical BC human cell line NCI-H720 is sensitive to everolimus (E), an m-TOR inhibitor, in terms of cell viability reduction, with a G0 cell-cycle arrest and a Cyclin D1 protein reduction. On the contrary, the typical human BC cell line NCI-H727 is not sensitive to E, despite the Cyclin D1 reduction. The ...

ea0014p595 | (1) | ECE2007

Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury

Di Somma Carolina , Rota Francesca , Rovere Silvia , Rosaria Ambrosio Maria , Fusco Alessandra , Corneli Ginevra , Bianchi Antonio , De Marinis Laura , degli Uberti Ettore Ciro , Lombardi Gaetano , Ghigo Ezio , Colao Annamaria , Aimaretti Gianluca

Aim of this study was to evaluate lipid profile and the severity of GHD, in a large group of TBI patients with or without GH deficiency. We assayed lipid profile (Total-, HDL- Cholesterol, Triglycerides) in 62 TBI subjects 12 months after TBI (41 M, 21 F, 13–81 yrs, BMI: 24.6±0.6 kg/m2), and in 62 sex-, age- and BMI-matched controls. Based on the GH peak after GHRH+ARG test, patients were stratified as: 1) severe GHD (GH peak ≤ 9 μg/l; <i...